Cargando…

Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis

INTRODUCTION: Various immunosuppressive regimens have been developed for the treatment of lupus nephritis (LN). This study aimed to compare the efficacy and safety of immunosuppressive regimens in adults with LN. METHODS: We systematically searched the PubMed, Embase, and Cochrane Central Register o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Nan, Jin, Shangyi, Yu, Chen, Zhao, Jiuliang, Wang, Qian, Tian, Xinping, Li, Mengtao, Zeng, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611487/ https://www.ncbi.nlm.nih.gov/pubmed/37901212 http://dx.doi.org/10.3389/fimmu.2023.1232244

Ejemplares similares

Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis
por: Peng, Liying, et al.
Publicado: (2020)

The Challenges and Future Perspective for the Management of Systemic Lupus Erythematosus in China: A Concise Annual Report of 2020
por: Tian, Xinping, et al.
Publicado: (2022)

Treatment of refractory lupus nephritis using leflunomide: A prospective study
por: Zhang, Shuo, et al.
Publicado: (2023)

Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020)

2022 Chinese guideline for the management of pregnancy and reproduction in systemic lupus erythematosus
por: Tian, Xinping, et al.
Publicado: (2023)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023)

New insights into the pathogenesis and management of rheumatoid arthritis
por: Jin, Shangyi, et al.
Publicado: (2022)

Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus
por: Li, Mengtao, et al.
Publicado: (2021)

Programmed Cell Death Pathways in the Pathogenesis of Idiopathic Inflammatory Myopathies
por: Shi, Jia, et al.
Publicado: (2021)

Comparative Efficacy and Safety of Biological Agents in the Treatment of Lupus Nephritis: A Network Meta-Analysis
por: Lee, Young Ho, et al.
Publicado: (2023)

Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
por: Bai, Wei, et al.
Publicado: (2022)

Progress in the Pathogenesis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus
por: Wang, Minhui, et al.
Publicado: (2022)

The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2016)

Efficacy and Safety of Biologic Agents for Lupus Nephritis: A Systematic Review and Meta-analysis
por: Chen, Pang, et al.
Publicado: (2023)

Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study
por: Yan, Qingran, et al.
Publicado: (2023)

Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review
por: Li, Mucong, et al.
Publicado: (2022)

Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort
por: Hu, Chaojun, et al.
Publicado: (2021)

Comparison of Different Test Systems for the Detection of Antiphospholipid Antibodies in a Chinese Cohort
por: Hu, Chaojun, et al.
Publicado: (2021)

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
por: Zhou, Shuang, et al.
Publicado: (2022)

Absolute quantification and characterization of oxylipins in lupus nephritis and systemic lupus erythematosus
por: He, Jingquan, et al.
Publicado: (2022)

Strongyloides Duodenitis in an Immunosuppressed Patient with Lupus Nephritis
por: Jegadeesan, Ramprasad, et al.
Publicado: (2018)

Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019)

Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients
por: Daamen, Andrea R., et al.
Publicado: (2023)

Renal Involvement and HBV Infection Are Common in Chinese Patients With Cryoglobulinemia
por: Bai, Wei, et al.
Publicado: (2021)

Belimumab in Lupus Nephritis: A Systematic Review and Meta-Analysis
por: Shrestha, Sanjeev, et al.
Publicado: (2021)

Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis
por: You, Hanxiao, et al.
Publicado: (2020)

Long-Term Survival and Death Causes of Systemic Lupus Erythematosus in China: A Systemic Review of Observational Studies
por: Wang, Ziqian, et al.
Publicado: (2015)

Mesangial cell: A hub in lupus nephritis
por: Liu, Mengdi, et al.
Publicado: (2022)

Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored
por: Huang, Can, et al.
Publicado: (2022)

RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China
por: Huang, Can, et al.
Publicado: (2022)

Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis
por: You, Hanxiao, et al.
Publicado: (2021)

Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry
por: Wang, Haiyan, et al.
Publicado: (2023)

Factors Associated With Renal Involvement in Primary Sjögren's Syndrome: A Meta-Analysis
por: Hong, Ruping, et al.
Publicado: (2020)

Comparative Effectiveness of Rituximab and Common Induction Therapies for Lupus Nephritis: A Systematic Review and Network Meta-Analysis
por: Li, Kang, et al.
Publicado: (2022)

CRAC Channel Controls the Differentiation of Pathogenic B Cells in Lupus Nephritis
por: Li, Xue, et al.
Publicado: (2021)

Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis
por: Singh, Jasvinder A., et al.
Publicado: (2016)

Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
por: Jiang, Nan, et al.
Publicado: (2022)

Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis
por: Zhang, Han, et al.
Publicado: (2023)

Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients
por: Huang, Can, et al.
Publicado: (2016)

Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
por: Zhou, Tianbiao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_truq724f4btj2d9a4nr8oqto2h